A detailed history of Citizens Financial Group Inc transactions in Annexon, Inc. stock. As of the latest transaction made, Citizens Financial Group Inc holds 35,000 shares of ANNX stock, worth $110,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,000
Holding current value
$110,950
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025

BUY
$1.38 - $2.73 $48,299 - $95,550
35,000 New
35,000 $84,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $151M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Citizens Financial Group Inc Portfolio

Follow Citizens Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Financial Group Inc with notifications on news.